Keith A. Goldan - 10 Feb 2025 Form 4 Insider Report for Syndax Pharmaceuticals Inc (SNDX)

Signature
/s/ Michael A. Metzger, Attorney-in-Fact
Issuer symbol
SNDX
Transactions as of
10 Feb 2025
Net transactions value
-$58,559
Form type
4
Filing time
12 Feb 2025, 17:16:46 UTC
Previous filing
07 Feb 2025
Next filing
19 May 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNDX Common Stock Sale $58,559 -3,777 -4% $15.50 90,746 10 Feb 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units.